
GoodMomS 2 Study
Overview
The Gestational Diabetes Management Study (GooDMomS) is a 6-month research program designed to help women who experienced gestational diabetes achieve a healthy weight after delivery and reduce their risk of developing type 2 diabetes.
Using an adaptive study design, all participants first take part in the Lifestyle Intervention, consisting of weekly educational virtual sessions and resources to support participants achieve their individualized weight loss goals. Participants who meet their weight loss goals within 4–6 weeks continue with the Lifestyle Intervention. Participants who do not meet their goals are randomly assigned to either the Enhanced Lifestyle Intervention or the Metformin Intervention.
The Enhanced Lifestyle Intervention includes biweekly educational virtual sessions along with additional guidance on healthy meal planning and online grocery shopping while the Metformin Intervention entails prescription and intake of Metformin, a medication commonly used for weight loss and prevention of type 2 diabetes.
Visit the GooDMomS website for more details.
Objective
The goal of this study is to learn which intervention is most effective for mothers who want to achieve a healthy weight and lower their risk of type 2 diabetes.
Our Partners



Other Studies

ALOFT Study
Long Term Follow-up of Women who undergo Uterine-Sparing Fibroid Treatments
This study will followup participants in the Comparing Options for Management: PAtient-centered REsults for Uterine Fibroids (COMPARE-UF) observational study to evaluate long-term quality of life measures 6-7 years following treatment for uterine fibroids.

COMPARE-UF
Sponsor: PCORI/AHRQ
The objective of this project was to enable women with uterine fibroids, particularly minority and low-income women and childbearing age women, to make informed decisions about management options based on the highest possible quality evidence.
To help achieve this objective, we assembled 8 US centers to form a registry of a geographically, racially, ethnically, and clinically diverse group of women with uterine fibroids.

DiabetesSisters Voices
This study aimed to develop and rigorously evaluate an online platform—the DiabetesSisters Network—to engage women with current or gestational diabetes. The goal was to create a virtual patient community that empowers participants to identify and prioritize topics for patient-centered and comparative effectiveness research.
